A Well-Being Intervention for People With IBS
Part of paid clinical trials in Madison, Wisconsin.
- Sponsor
- University of Wisconsin, Madison
- Study ID
- NCT07600047
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Irritable Bowel Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Well-Being Intervention — BEHAVIORALThe intervention will be once weekly over a 15-week period, lasting approximately one hour per session.
Study Details
The purpose of this randomized behavioral clinical trial is to examine whether a well-being intervention can improve both psychological well-being and physical outcomes in adults with Irritable Bowel Syndrome (IBS). The study aims to assess whether this intervention decreases anger, anxiety, and depression; increases self-esteem, empathy, and hope; and improves quality of life indicators such as IBS symptom severity, sleep quality, fatigue, and diet. Participants can expect to be on study for up to 9 months.
Key Dates
- Start date
- Aug 31, 2026
- Status verified
- May 2026
- Primary completion
- Aug 31, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: Well-Being Intervention
- Active Comparator: Waitlist Control (delayed Well-Being Intervention)
Primary Outcome Measure
Anger measured by PROMIS Anger Scale Score [ Time Frame: data collected up to 17 weeks with a 4 week follow up at 21 weeks on study for the first intervention and waitlist-control, data collected up to 34 weeks with a 4 week follow up at 38 weeks on study to complete data collection in the crossover group ]
Central Contacts
- Mark Benson, MD608-263-1995
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UW Health Digestive Health Center | Madison | Wisconsin | 53705 | - |
Find similar trials in Madison, WI
Related Studies
- Mucosal and Microbiota Changes During Acute CampylobacteriosisRecruiting · Mayo Clinic · Rochester, Minnesota
- Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in ChildrenPHASE2 · Recruiting · AbbVie · Hot Springs, Arkansas
- A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)PHASE3 · Enrolling By Invitation · AbbVie · Corona, California
- Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel SyndromeRecruiting · The Cooper Health System · Camden, New Jersey